Hummel, Michael
Hegewisch-Becker, Susanna
Neumann, Jens H. L.
Vogel, Arndt
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Accepted: 6 April 2021
First Online: 14 July 2021
Declarations
:
: A. Vogel declares having received honoraria in the last 3 years, although not in relation to the present review, from the following pharmaceutical companies: Bristol-Myers Squibb, Merck, MSD, Pierre Fabre, and Roche. M. Hummel received support from Novartis, BMS, MSD, and Pierre Fabre for various activities. S. Hegewisch-Becker and J.H.L. Neumann declare that they have no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.
: The supplement containing this article is not sponsored by industry.